Meeder Asset Management »

Monopar Therapeutics shares owned by Meeder Asset Management

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Meeder Asset Management from 13F filings

Historical chart of Meeder Asset Management investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Meeder Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Meeder Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $65k 994 65.30

More positions owned by Meeder Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Meta Platforms Cl A (META)
Ishares Tr Jpmorgan Usd Emg (EMB)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
General Dynamics Corporation (GD)
Mastercard Incorporated Cl A (MA)
Bank of New York Mellon Corporation (BK)
Eli Lilly & Co. (LLY)
State Street Corporation (STT)
Johnson & Johnson (JNJ)

View all positions for Meeder Asset Management

Top funds holding Monopar Therapeutics

Henderson Group
Adage Capital Partners GP
RA Capital Management
Saturn V Capital Management
Vanguard Group
BlackRock
ADAR1 Capital Management
Wellington Management Company
Siren
Deerfield Management Company
TCG Crossover Management
Polar Capital Holdings
Geode Capital Management
Deep Track Capital
Vivo Capital

View all funds holding Monopar Therapeutics